Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs – a systematic review and meta-analysis protocol | Synapse
March 3, 2026Open Access
Direct, indirect and intangible costs incurred by leptospirosis patients: the magnitude, aspects and methods of assessing the costs – a systematic review and meta-analysis protocol
Key Points
Leptospirosis patients face direct, indirect, and intangible costs that may affect their quality of life.
Assessment includes evaluating the magnitude and aspects of these costs systematically.
The analysis is based on a meta-analysis protocol registered under CRD 42024585056 for structured evaluation.
Findings could inform healthcare policies and economic evaluations surrounding leptospirosis management.